Free Trial
CVE:MPH

Medicure (MPH) Stock Price, News & Analysis

Medicure logo
C$0.79 -0.10 (-11.24%)
As of 03/25/2025

About Medicure Stock (CVE:MPH)

Key Stats

Today's Range
C$0.79
C$0.79
50-Day Range
C$0.65
C$0.89
52-Week Range
C$0.65
C$1.26
Volume
1,000 shs
Average Volume
4,670 shs
Market Capitalization
C$8.24 million
P/E Ratio
N/A
Dividend Yield
2.24%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing Sodium Nitroprusside injection, and Generic ANDA 2 and 3 for acute cardiology; and TARDOCAL, to treat neurological indications. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Remove Ads
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MPH Stock News Headlines

Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
Medicure Inc. (NGQ1.F)
Medicure Inc. (MPH.V)
MPH:CA Medicure Inc.
See More Headlines

MPH Stock Analysis - Frequently Asked Questions

Medicure's stock was trading at C$0.88 at the beginning of the year. Since then, MPH shares have decreased by 10.2% and is now trading at C$0.79.
View the best growth stocks for 2025 here
.

Medicure Inc. (CVE:MPH) announced its quarterly earnings results on Wednesday, May, 24th. The company reported ($0.33) earnings per share for the quarter, missing analysts' consensus estimates of $0.04 by $0.37. The company earned $8.71 million during the quarter, compared to the consensus estimate of $14.50 million. Medicure had a negative net margin of 9.65% and a negative trailing twelve-month return on equity of 10.18%.

Shares of MPH stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medicure investors own include Dollarama (DOL), Alimentation Couche-Tard (ATD.B), Canoe EIT Income Fund (ENDTF), Allena Pharmaceuticals (ALNA), Hudbay Minerals (HBM), ProMetic Life Sciences (PLI) and Athersys (ATHX).

Company Calendar

Last Earnings
5/24/2017
Today
3/31/2025

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:MPH
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
12.10
P/E Growth
N/A
Net Income
C$-2,033,997.47
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$21.08 million
Cash Flow
C$0.32 per share
Price / Cash Flow
2.49
Book Value
C$1.91 per share
Price / Book
0.41

Miscellaneous

Free Float
N/A
Market Cap
C$8.24 million
Optionable
Not Optionable
Beta
0.90
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (CVE:MPH) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners